C

Changchun High & New Technology Industries Group Inc
SZSE:000661

Watchlist Manager
Changchun High & New Technology Industries Group Inc
SZSE:000661
Watchlist
Price: 109.6 CNY -3.02% Market Closed
Market Cap: 44.4B CNY
Have any thoughts about
Changchun High & New Technology Industries Group Inc?
Write Note

Changchun High & New Technology Industries Group Inc
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Changchun High & New Technology Industries Group Inc
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
C
Changchun High & New Technology Industries Group Inc
SZSE:000661
Short-Term Debt
ÂĄ464.2m
CAGR 3-Years
73%
CAGR 5-Years
13%
CAGR 10-Years
20%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Short-Term Debt
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Short-Term Debt
ÂĄ1.1B
CAGR 3-Years
15%
CAGR 5-Years
6%
CAGR 10-Years
57%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Short-Term Debt
ÂĄ249m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
37%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Short-Term Debt
ÂĄ4.1B
CAGR 3-Years
20%
CAGR 5-Years
20%
CAGR 10-Years
21%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Short-Term Debt
ÂĄ318.9m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Changchun High & New Technology Industries Group Inc
Glance View

Market Cap
44.3B CNY
Industry
Pharmaceuticals

Changchun High & New Technology Industries (Group), Inc. engages in the research, development, production, and sale of biopharmaceuticals and proprietary Chinese medicines. The company is headquartered in Changchun, Jilin and currently employs 8,045 full-time employees. The Company’s main products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines and rabies vaccines for human use, among other. The firm is also involved in real estate development and property management businesses. The firm operates its business mainly in domestic market.

Intrinsic Value
186.04 CNY
Undervaluation 41%
Intrinsic Value
Price
C

See Also

What is Changchun High & New Technology Industries Group Inc's Short-Term Debt?
Short-Term Debt
464.2m CNY

Based on the financial report for Sep 30, 2024, Changchun High & New Technology Industries Group Inc's Short-Term Debt amounts to 464.2m CNY.

What is Changchun High & New Technology Industries Group Inc's Short-Term Debt growth rate?
Short-Term Debt CAGR 10Y
20%

Over the last year, the Short-Term Debt growth was 194%. The average annual Short-Term Debt growth rates for Changchun High & New Technology Industries Group Inc have been 73% over the past three years , 13% over the past five years , and 20% over the past ten years .

Back to Top